Literature DB >> 32515738

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial.

Yoshinobu Onuma1, Bernard Chevalier, Masafumi Ono, Àngel Cequier, Dariusz Dudek, Michael Haude, Didier Carrié, Manel Sabaté, Stephan Windecker, Richard R Rapoza, Nick E J West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Íñiguez-Romo, Patrick W Serruys.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32515738     DOI: 10.4244/EIJ-D-20-00024

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  1 in total

1.  Five-year comparative study of thin-strut rapamycin-eluting bioabsorbable scaffold with metallic drug-eluting stent in porcine coronary artery.

Authors:  Yaokun Liu; Bo Zheng; Bin Zhang; Robert Ndondo-Lay; Fangfang Nie; Naijie Tang; Yongsheng Miao; Jianping Li; Yong Huo
Journal:  Front Cardiovasc Med       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.